Qi-Ying Hu

Qi-Ying Hu

Company: Corti Therapeutics

Job title: Chief Executive Officer

Seminars:

PANEL DISCUSSION: Exploring the Future of Extra-Hepatic Delivery Systems: Overcoming Barriers & Meeting Unmet Needs Across Therapeutic Modalities 9:00 am

What are the key strategies for designing next-gen delivery systems that can target extra-hepatic tissues and avoid accumulation in the liver to enable effective RNA therapeutics for a broader range of diseases? What challenges are we facing in achieving efficient extra-hepatic delivery, and what is a realistic timeline for consistently overcoming barriers to target specific…Read more

day: Conference Day One

Workshop A – Enhancing the Precision of Lipid-Based Delivery Systems Through Conjugation & Active Targeting to Unlock Effective Therapeutic Delivery to Novel Organs & Tissues 9:00 am

Manipulating the tropism of your delivery system via targeting systems is a promising approach to improve the precision and efficacy of lipid-based delivery systems. However, it presents new challenges including lipid and conjugation chemistry, CMC complexities, in vitro to in vivo translatability, promoting endosomal escape and avoiding accumulation in the liver. This workshop will focus…Read more

day: Pre-Conference Workshop Day

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.